Skip to main content
Premium Trial:

Request an Annual Quote

Proteros Providing X-ray Protein Structures to Nimbus for Drug Targets

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Proteros today announced a deal with Nimbus Discovery to provide X-ray protein crystal structures for drug targets.

Under the terms of the deal, Proteros will provide structures from its Gallery Structure catalogue of ready-to-use proteins for X-ray structure analysis of protein-ligand complexes, and gene-to-structure projects for novel biological targets, the German firm said.

Its high-throughput crystallography platform and proprietary technologies will be used to provide Nimbus with "rapid turnaround in support of their discovery projects," Proteros said, adding it will generate customized structures for Nimbus' proprietary programs and clinical candidates.

Financial and other terms of the deal were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.